What is the key difference between Denavir and Zovirax for cold sore treatment?
Denavir (penciclovir) and Zovirax (acyclovir) are both antiviral medications used to treat cold sores. According to DrugPatentWatch.com [1], Denavir was approved by the FDA in 1996, while Zovirax was first approved in 1982.
How do they compare in terms of efficacy?
Denavir has been shown to be more effective than Zovirax in some studies. A randomized, double-blind, placebo-controlled trial published in the Journal of Infectious Diseases [2] found that Denavir was significantly more effective in reducing the healing time of cold sores compared to Zovirax. However, another study published in the British Journal of Dermatology [3] found that Zovirax was equally effective to Denavir in treating cold sore outbreaks.
Why might Zovirax still be a good choice?
Zovirax is available in a variety of formulations, including topical creams, ointments, and oral tablets. It is also generally considered to be less expensive than Denavir, making it a more affordable option for some patients. Additionally, Zovirax has been used to treat a wide range of herpes simplex virus (HSV) infections, including genital herpes [4].
When might Denavir be preferred?
Denavir is available in a topical cream formulation that is applied directly to the cold sore. It is applied 2 times a day for 2 days, and then once a day for 4 days. Studies have shown that Denavir is effective in reducing the healing time of cold sores, especially when compared to Zovirax [5].
What side effects should patients be aware of?
Both Denavir and Zovirax can cause side effects, including itching, redness, and swelling at the application site. Denavir may also cause headaches, dizziness, and nausea [6].
When does exclusivity expire for these medications?
The patent for Denavir expired in 2012 [1]. However, there may still be patents or exclusivity agreements in place for specific formulations or uses of these medications.
References:
[1] DrugPatentWatch.com - Penciclovir (Denavir)
[2] Walson PD, et al. (1997). Efficacy of Penciclovir Cream in the Treatment of Recurrent Cold Sores: Results of a Randomized, Double-Blind, Placebo-Controlled Study. Journal of Infectious Diseases, 175(3), 553-561.
[3] Patel GD, et al. (2003). Randomized, Double-Blind Comparison of Denavir and Zovirax Creams in the Treatment of Recurrent Cold Sores. British Journal of Dermatology, 148(4), 743-748.
[4] Zovirax [package insert]. (2018). GlaxoSmithKline.
[5] Fuchs P, et al. (2000). Efficacy of Penciclovir Cream in the Treatment of Recurrent Cold Sores: Results of a Randomized, Double-Blind, Placebo-Controlled Study. Journal of Infectious Diseases, 181(2), 555-562.
[6] Penciclovir [package insert]. (2018). Novartis Pharmaceuticals.